Soligenix, Inc.
SNGX · NASDAQ
Bulios Fair Price
$0.25
31.3% downside
Current Price
$0.36
According to Bulios Fair Price, SNGX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Soligenix, Inc. (SNGX) is a biopharmaceutical company that focuses on the development and commercialization of drug products for the treatment of a range of diseases, including rare diseases and serious medical conditions. The company specializes in utilizing biotechnology and pharmacology for the development of therapeutic solutions. Soligenix also emphasizes research and clinical trials to confirm the efficacy and safety of its products. Their therapeutic innovations have the potential to help patients suffering from challenging-to-treat conditions. Shares of Soligenix, Inc. (SNGX) can be an interesting choice for investors tracking the biopharmaceutical sector and the development of therapeutic treatments.
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher J. Schaber
Employees
14
Headquarters
Princeton
Upcoming events
Earnings
Upcoming earnings report